* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
2'-F-RNA Neurotensin receptor NTS-1 Protein 0.37 nM (reported value)Binding Buffer (SHMCK buffer containing 0.1% (w/v) HSA, 0.2% (w/v)
CHAPS, 0.04% (w/v) CHS, and 0.1% (w/v) LM)N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Daniels et al. "Generation of RNA Aptamers to the G-Protein-Coupled
Receptor for Neurotensin, NTS-1." Journal of Analytical Biochemistry, 305(2002): 214-226.
Have your aptamer oligo synthesized by one of our AFFILIATES
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
2'-F-RNA
Neurotensin receptor NTS-1
Protein
0.37 nM (reported value)
Binding Buffer (SHMCK buffer containing 0.1% (w/v) HSA, 0.2% (w/v)
CHAPS, 0.04% (w/v) CHS, and 0.1% (w/v) LM)
N/A
If the oligo is a known aptamer sequence: For binding studies, perform a refolding program to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
